Characteristics of Patients With RP
. | Diagnosis . | More Specific Context . | Age/Sex . | Duration . | % of PCs . | CRP (mg/L)* . | Ig (g/L)* . |
---|---|---|---|---|---|---|---|
RP1 | T-cell lymphoma | — | 69/F | ND | 20† | 66 | ND |
RP2 | B-cell lymphoma | — | 87/F | ND | 11‡ | ND | ND |
RP3 | Acute myeloid leukemia | — | 66/M | ND | 11‡ | ND | ND |
RP4 | Rheumatoid arthritis | At the time of cardiac surgery | 78/F | ND | 10† | ND | ND |
RP5 | Infectious mononucleosis | Treatment with cyclosporin A | 8/M | 10 d | 50† | 21 | 36 |
RP6 | Acute respiratory infection | B-cell lymphoma | 42/M | 7 d | 20† | 20 | 43 |
RP71-153 | EBV reactivation | Aplasia1-155 | 27/M | NE | 79† | 270 | 34 |
RP8 | Acute respiratory infection | — | 54/M | 6 d | 8† | ND | ND |
RP9 | Acute respiratory infection | — | 70/M | ND | 12‡ | 108 | 28 |
RP10 | Primary amyloidosis | Aplasia1-155 | 49/M | 5 d | 12† | ND | ND |
. | Diagnosis . | More Specific Context . | Age/Sex . | Duration . | % of PCs . | CRP (mg/L)* . | Ig (g/L)* . |
---|---|---|---|---|---|---|---|
RP1 | T-cell lymphoma | — | 69/F | ND | 20† | 66 | ND |
RP2 | B-cell lymphoma | — | 87/F | ND | 11‡ | ND | ND |
RP3 | Acute myeloid leukemia | — | 66/M | ND | 11‡ | ND | ND |
RP4 | Rheumatoid arthritis | At the time of cardiac surgery | 78/F | ND | 10† | ND | ND |
RP5 | Infectious mononucleosis | Treatment with cyclosporin A | 8/M | 10 d | 50† | 21 | 36 |
RP6 | Acute respiratory infection | B-cell lymphoma | 42/M | 7 d | 20† | 20 | 43 |
RP71-153 | EBV reactivation | Aplasia1-155 | 27/M | NE | 79† | 270 | 34 |
RP8 | Acute respiratory infection | — | 54/M | 6 d | 8† | ND | ND |
RP9 | Acute respiratory infection | — | 70/M | ND | 12‡ | 108 | 28 |
RP10 | Primary amyloidosis | Aplasia1-155 | 49/M | 5 d | 12† | ND | ND |
The percentage of plasma cells was either defined in the total population, ie, on blood smears (
) or in PBMNC, ie, on cytospins (
).
Abbreviations: ND, not done; NE, not evaluable (patient died during plasmacytosis).
Normal values: CRP, <3 mg/L; Ig, <15 g/L.
This case has been extensively described elsewhere.18
Aplasia after stem cell transplantation (RP7, allogeneic; RP10, autologous).